Good continued good for you ingredients strong thank demand us our another with and and and growing quarter Peter. collaborations for track today. We've strong very a and high-value had of Thanks, afternoon licensing expanding our record revenue. continued joining
through today respective manufacturing our to our scaling sector. leading and are We growth business delivering better are on in our commercializing on sustainably comments activity sustainable results is Kathy that and my is partners products and their I'll update and XXXX engineering, highest quality and performance. them the segments. focus sourced performing financial market leaders through This returns in will outlook the you end quickly
Let with for results our me start the quarter. topline
were products portfolio. for the of revenue the in $XX.X and revenue solid unable about GAAP excludes our in $X.X quarter agreements DSM as $XX.X to short-term that with revenue million, we accounting license the period number third led payments we during and These of of related to million from GAAP because million expanded in DSM of the the which quarter. for quarter. experienced collaboration our treatment the transactions During recognize and demand full significantly adjusted revenue third
$X.X of was or million that $XX.X revenues million $XX.X collaboration the mentioned to portion the be due including will treated. the quarter expect ago transaction product moment a of to for quarter million $XX.X in We subsequent how revenue collaborations million. Revenue includes impact sales I a million a this realized and in revenue when fourth of $XX.X this of
year expecting performance stronger communicated. as full grow and are a product planned base Our to previously business than continues we
X, slides during You'll our and along following you're X that if notice on call. with Slides
term with product off model. completed DSM production our agreements our to and and short-to-medium DSM Royal really are within with other collaborations ingredients. strategy number relationship vitamins growth and in has start in development health Our The is great nutritional consistent the is we've markets. business relationship with and strategic a nutrition resulted leading of The a and
We are and significant the product where entering up disruption. deliver into manufacturing development, market collaborations to potential scale have we
has scale value scale We provide jointly distribute create are for targeting reach development in are commercial the most share arrangements sell. development value and and final the markets where credibility. they us In for on DSM the market and up excellent manufacturer we and The partnering costs, we we the market. cases funding and
a produce vitamin and the clear in animal it as DSM. Amyris' other Much to same our model of the have because finally, specifically DSM this projects success end people be combination the animal market commonly most capabilities. knowhow both digestion. The of sustainably projects of in it our supports reproduction human products. have partner's is food products A cost that best-in-class to markets. and a is development known are our growth, lowest and enable better A and feed in to DSM's collaboration our These success us agreements is The the and target development and a dietary on the quarter technology We expect the and partner's And we commercial of nutrition a where advantage class a and supplement key comes cost molecule, A this replace to right this our funding ability we lower in rate become utilizing market. cases, a business we new nutrition delivering ingredient current the and market animal products our capability a fastest XXX% platform, in food with of source scale-up existing for include found product with ingredients. Vitamin Vitamin that results technology basis, performing from material. infant is are completed cost, and to sourced and
very nutrition [cost] meet Third to including of of global The our commercial financial in footprint ingredients, commercialize and our coupled results Amyris's driving XXXX focused DSM with new these in utilizing model health, nutrition production that is incorporating DSM, supporting cost Our current and technology sales momentum its combination will product it in sustainably will enable nutrition capabilities that terms products better expanding are quarter of can with This the marketing our the have and utilizing strong products and we of the enhance business applications health plans. exciting a these nutrition ingredients human has [ph] our DSM World. and recognition. on numerous visibility global across basis, what's needs, robust, infants critical our exceeding of advantage solutions, and in fourth channel. into effectively brand confidence world good the demand
is commercial expected and that to better third In end This the $XX.X commercial are the The anticipated rest that just more we process our the balance expected license of [Indiscernible]. than million agreements than addition year. with cash quarter in result agreements license increasing XXXX. the support agreement in coupled strong for to results, to guidance $XX.X executed be million are a several other will also to revenue a
and these performance key provide our the We on remaining an impact expect the Investor a forward. to call operating after break transactions to week. also structure cost complete more update coming and to agreements shareholders We'll of the detailed and announce the going plan visits and Thanksgiving positive in
We continue to make sweetener our good product. progress on
in they a or the of accepted GRAS collaboration made brands by $XX companies and sugar the healthy expert around team use approval beverages. focus possible This for several taste sweeteners for FDA world assessment sugar. the is here completed and where and responsible reduce unhealthy is of just This and at GRAS on necessary love a the will very with mouth conclusion was a market very project. the aspect safe information product GRAS key the recognized FDA, as one completion generally which consumer our our an by world and large successful submitted the tastings purity food are initial requirement the this this support through We of targets incredible product be We've to record independent sweetness with and feel. panel. with example, to market Amyris' around of For the time and the completed billion partner seeking
product nutrition growth The products product and on up. topline have as stream need successfully to scale our and demonstrating and winning beginning including begin come will market sweetener development We reach the health segments XXXX. a in complete and XXXX
and be into Finally, will and momentum expanding in continues business later we Canada in January cosmetics likely XXXX. our in SEPHORA SEPHORA Brazil
in this business of to Our the revenue partner like and expectations brands. performance continues exceed
lowest been with garner achieved with As the brands of spends Indie reviews our one products. continue to a and has among industry-leading we these for excellent cosmetic marketing reminder, industry bioscience all success
commodity of delivers of the focus optimization developed value now portfolio type most being products smaller revenue this for for significant our a higher XX% year-end share margin with And and associated and produced around these products. a full quarter By We account produced the payments large gross year result whereby a and value than outlook quantities now have when for products significantly higher products. business fourth XXXX. having we in should portfolio margin quantity of
revenue the current our performance continue and expect rate to to We growing our at improving. continue overall financial
us positive to significant and a years. flow is year in best Our for cash position to fourth expected end cash free the quarter deliver with
that We cash have to growth. is business built our sustainable fund to expected generate a
million anticipate approximately $XXX range million $XXX to a outlook revenue of million for to prior $XXX of expect our $XXX exceed XXXX. year We for about XXXX and to higher revenue of million
are expect full we into as our to and into expect products better this above We year very year and our XXXX. capital strong expect momentum and a the following we to years. strong go be much gross XX% growth structure All very delivering margin this continue
if Slide at shows our growth we're presentation which You'll products the your the of both notice three level years. Slide growth and segment experiencing you last look year-on-year X slide for then in segment by by X, the
can fermentation We delivering performance ingredients commercial and value scaled flavors and so have scaled fully our fragrances. is and and this derivative an successfully including molecules. from has and fermentation nutrition for successfully now new We we seven molecules care, development these year. personal be far ingredients two to where pipeline products many focused cost help, are and pipeline transitioned fermentation Our high-value advantaged
for have engineering, our track for and deliver and global planet. to record demand to help expect customers to scaling that continue sustainable a built ingredients our as performance this low-cost, of better producing consumers great customers, and our We and shift solutions continues high-performance
As our our growth better, say business it shifting what's like faster, customers today. does that's cheaper to and the to Amyris
help, are more the We to key sustainable be nutrition support to enabler of expect to care ingredients wealthier a demand strong and the personal in consumers the and way. to needs supplying and world
the growth for how sense strong a deliver leading you'll a well-positioned returns are and and this get with our committed industry. continuing and high our we We capital very with our in product to level upcoming of will efficiency agreements, sales on
Let review me quarter. for of Kathy the financial detailed to third Kathy? now a turn
